BDBM411351 US10385031, Compound 057::US10774056, Compound 057::US11542242, Compound 057

SMILES Nc1ccc(cc1NC(=O)c1nc(cs1)N1CCNCC1)-c1ccncc1

InChI Key InChIKey=HMDYBHCYFSWGLM-UHFFFAOYSA-N

Data  9 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 9 hits for monomerid = 411351   

TargetHistone deacetylase 1(Homo sapiens (Human))
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM411351(US10385031, Compound 057 | US10774056, Compound 05...)
Affinity DataIC50: >500nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 2(Homo sapiens (Human))
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM411351(US10385031, Compound 057 | US10774056, Compound 05...)
Affinity DataIC50: <1.00E+3nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 3(Homo sapiens (Human))
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM411351(US10385031, Compound 057 | US10774056, Compound 05...)
Affinity DataIC50: >500nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 1(Homo sapiens (Human))
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM411351(US10385031, Compound 057 | US10774056, Compound 05...)
Affinity DataIC50: >500nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 3(Homo sapiens (Human))
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM411351(US10385031, Compound 057 | US10774056, Compound 05...)
Affinity DataIC50: >500nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 3(Homo sapiens (Human))
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM411351(US10385031, Compound 057 | US10774056, Compound 05...)
Affinity DataIC50: >500nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 1(Homo sapiens (Human))
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM411351(US10385031, Compound 057 | US10774056, Compound 05...)
Affinity DataIC50: >500nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 2(Homo sapiens (Human))
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM411351(US10385031, Compound 057 | US10774056, Compound 05...)
Affinity DataIC50:  255nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 2(Homo sapiens (Human))
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM411351(US10385031, Compound 057 | US10774056, Compound 05...)
Affinity DataIC50:  255nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent